171 related articles for article (PubMed ID: 7395496)
1. Human pituitary tumours in organ culture with correlation to clinical data.
Anniko M; Wersäll J
Acta Otolaryngol; 1980; 89(3-4):249-57. PubMed ID: 7395496
[TBL] [Abstract][Full Text] [Related]
2. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and prolactin in tissue culture of pituitary adenoma.
Demura R; Kubo O; Odagiri E; Nomura K; Yamaguchi H
Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
[TBL] [Abstract][Full Text] [Related]
6. [The behavior of the human hypophyseal tumor in vitro. An analysis of tumor biology in 51 consecutive operated cases].
Anniko M
Laryngol Rhinol Otol (Stuttg); 1982 Sep; 61(9):534-4. PubMed ID: 6128641
[TBL] [Abstract][Full Text] [Related]
7. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
8. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
Atkin SL; Landolt AM; Foy P; Jeffreys RV; Hipkin L; White MC
Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
[TBL] [Abstract][Full Text] [Related]
9. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
Lei T; Bai X; Liu K; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1998; 18(3):161-3. PubMed ID: 10806816
[TBL] [Abstract][Full Text] [Related]
10. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
11. Inversely related evolution of growth hormone and prolactin secretions in long-term tissue cultures of human pituitary adenomas from acromegalic patients.
Loras B; Trouillas J; Li Y; Durand A; Girod C; Bertrand J
In Vitro Cell Dev Biol; 1988 Nov; 24(11):1064-70. PubMed ID: 3192504
[TBL] [Abstract][Full Text] [Related]
12. Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.
Anniko M; Wersäll J
Acta Pathol Microbiol Scand A; 1981 Jan; 89(1):41-7. PubMed ID: 7223426
[TBL] [Abstract][Full Text] [Related]
13. Morphological changes in bromocriptine-treated pituitary tumours.
Anniko M; Wersäll J
Acta Otolaryngol; 1983; 96(3-4):337-53. PubMed ID: 6637451
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone secreting pituitary adenomas are heterogeneous in cell culture and commonly secrete glycoprotein hormone alpha-subunit.
White MC; Newland P; Daniels M; Turner SJ; Mathias D; Teasdale G; Kendall-Taylor P
Clin Endocrinol (Oxf); 1986 Aug; 25(2):173-9. PubMed ID: 2431811
[TBL] [Abstract][Full Text] [Related]
15. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium.
Lipson LG; Beitins IZ; Kornblith PL; McArthur JW; Friesen HG; Kliman B; Kjellberg RN
Acta Endocrinol (Copenh); 1979 Mar; 90(3):421-33. PubMed ID: 218413
[TBL] [Abstract][Full Text] [Related]
16. DNA and S-phase representation in human growth hormone producing pituitary adenomas.
Hulting AL; Tribukait B; Bergstrand G; Werner S
Acta Endocrinol (Copenh); 1985 Jul; 109(3):295-303. PubMed ID: 4024848
[TBL] [Abstract][Full Text] [Related]
17. Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours.
Adams EF; Mashiter K
Neurosurg Rev; 1985; 8(3-4):135-40. PubMed ID: 4033960
[TBL] [Abstract][Full Text] [Related]
18. The levels and subcellular distribution of hormones and marker enzymes in pituitaries from control subjects and patients with prolactinomas, acromegaly or functionless pituitary tumours.
De Marco L; Mashiter K; Peters TJ
Clin Endocrinol (Oxf); 1984 Nov; 21(5):515-23. PubMed ID: 6388910
[TBL] [Abstract][Full Text] [Related]
19. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
Hulting AL; Wersäll J; Werner S
Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
